HIV

Government of Canada announces appointment to the Canadian Centre on Substance Use and Addiction

Retrieved on: 
Thursday, March 28, 2024

Scott Elliott is appointed as a Director of the CCSA Board of Directors, for a term of three years.

Key Points: 
  • Scott Elliott is appointed as a Director of the CCSA Board of Directors, for a term of three years.
  • He is currently the Chief Executive Officer of the Dr. Peter Centre (DPC) in Vancouver, British Columbia.
  • The Government of Canada is committed to appointing highly qualified candidates to best serve the interests of Canadians.
  • "I am very pleased to announce the appointment of Mr. Elliott to the Canadian Centre on Substance Use and Addiction.

Fiocruz and Caring Cross Announce Collaboration Agreement to Enable Access to Affordable CAR-T Therapy in Brazil and Latin America

Retrieved on: 
Tuesday, March 26, 2024

RIO DE JANEIRO and GAITHERSBURG, Md., March 26, 2024 /PRNewswire/ -- Fundação Oswaldo Cruz (Fiocruz), a foundation from the Brazilian government's Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic diseases in Brazil, including CAR-T cell therapies for leukemia, lymphoma, and HIV infection.

Key Points: 
  • CAR-T cell therapies represent a revolutionary treatment, harnessing the body's own immune cells to precisely target and destroy infected cells.
  • Caring Cross has developed manufacturing processes that significantly decreases the material cost of manufacturing CAR-T cell therapy products.
  • The agreement with Fiocruz, exclusive to Brazil and Latin America, will not only enable affordable access of CAR-T cell therapies for the Brazilian public health system, but will allow access of critical materials and training needed to manufacture CAR-T cells for other organizations in Brazil and Latin America.
  • "Our collaboration with Fiocruz marks a significant step forward in making CAR-T cell therapies more accessible in Brazil and Latin America," said Boro Dropulić, Ph.D., Executive Director of Caring Cross.

RWJBarnabas Health and Rutgers Health to Showcase Breakthrough Cardiology Data at the American College of Cardiology Scientific Session & Expo

Retrieved on: 
Monday, March 25, 2024

WEST ORANGE, N.J., March 25, 2024 /PRNewswire/ -- Physician-scientists from RWJBarnabas Health and Rutgers Health will present an extensive portfolio of innovative cardiovascular data from their clinical research program at the American College of Cardiology's (ACC) Annual Scientific Session & Expo in Atlanta, Georgia on April 6 to 8, 2024. A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.

Key Points: 
  • A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.
  • RWJBarnabas Health cardiac centers of excellence are nationally recognized for patient care and superior outcomes, including being named as one of Becker's top 100 Great Heart Programs in the country and recognized by American College of Cardiology as a Proven Quality Program.
  • Prior studies suggest that distinct patient subgroups with aortic stenosis may experience left ventricular systolic and diastolic dysfunction before the development of severe AS.
  • The study included patients who had received an angiogram done within 14 days of the CMR.

$1 Million Fund Honoring LGBTQ+ Champion Glen Spencer is Making Big Impacts

Retrieved on: 
Tuesday, March 19, 2024

PHOENIX, March 19, 2024 /PRNewswire/ -- Spectrum Medical Care Center and its executive leadership established the "Glen Spencer Ending the HIV Epidemic Fund" in 2022 to honor Glen Spencer's legacy and dedication to increasing HIV awareness throughout the LGBTQ+ community. It is focused on curtailing HIV infections and promoting public health by committing $1 million over the course of four years.

Key Points: 
  • It is focused on curtailing HIV infections and promoting public health by committing $1 million over the course of four years.
  • "This is why fund recipients are our valued partners; their services are already touching the lives of many people.
  • Together we are all creating a wide safety net, one that we believe would make Glen Spencer very proud."
  • "Glen was bigger than life and is still sorely missed," said Spectrum Medical Care Center Director of Marketing and Community Engagement Victor Avila.

Combatting Overdoses: The SPOT's Mission to Prevent Spring Break Deaths

Retrieved on: 
Tuesday, March 12, 2024

Emelina Martinez, Safe Syringe Exchange Services Manager for The SPOT, states, "Many spring breakers don't realize that the substances they are purchasing on the street might be laced with fentanyl or xylazine.

Key Points: 
  • Emelina Martinez, Safe Syringe Exchange Services Manager for The SPOT, states, "Many spring breakers don't realize that the substances they are purchasing on the street might be laced with fentanyl or xylazine.
  • Our goal is to reach more people this year, distributing more Narcan with the hope of saving even more lives."
  • This emphasizes the critical need for awareness and harm reduction efforts, such as those undertaken by The SPOT, to mitigate the negative consequences of substance use during spring break and beyond.
  • In addition to its primary mission of harm reduction, The SPOT operates as a mobile medical clinic, offering a range of free medical services.

Unravel: The Power and Politics of Textiles in Art – Barbican show reveals the medium’s subversive nature

Retrieved on: 
Wednesday, April 3, 2024

Textile art is having a revival, as the artists on show at the Barbican exhibition, Unravel: The Power and Politics of Textiles in Art, attest.

Key Points: 
  • Textile art is having a revival, as the artists on show at the Barbican exhibition, Unravel: The Power and Politics of Textiles in Art, attest.
  • But it also invites deeper reflection on the societal shifts that have prompted a revival of the art form.
  • The exhibition focuses on this subversive nature of textiles in contemporary art through works by artists including Feliciano Centurión.

The changing landscape of exhibiting textiles

  • Their three-dimensional fibre structures both physically and metaphorically reclaimed space in an art world largely dominated by their male counterparts.
  • Their practices often employ textiles and recycled elements, transcending the European dichotomy between art and craft.
  • Private galleries are exerting a growing influence on the art world, and have contributed significantly to the visibility of fibre art and textiles.
  • Moreover, the practicality of textiles, being easier to transport and install compared to paintings, further enhances their appeal to galleries.
  • The resurgence of textiles in contemporary art provides a vital opportunity for conversation and revision within both the art world and society at large.


Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.
Francesca Stocco does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Hope is not the same as optimism, a psychologist explains − just look at MLK’s example

Retrieved on: 
Wednesday, April 3, 2024

But I want you to know tonight that we, as a people, will get to the Promised Land.” Twenty-two hours later, he was assassinated.

Key Points: 
  • But I want you to know tonight that we, as a people, will get to the Promised Land.” Twenty-two hours later, he was assassinated.
  • He was not optimistic that he would reach the “Promised Land,” yet he was hopeful about the ultimate goal.
  • Self-help books on optimism are lined with hacks – like imagining your greatest possible self or focusing on the best-case scenario.
  • It is a mindset that helps people endure challenges, tackle them head-on and keep their eyes on the goal – a virtue that King and other community leaders exemplify.

We, not me

  • Hope is stronger than optimism at predicting academic success and people’s ability to cope with pain.
  • Plenty of scientific evidence suggests that hope improves individuals’ health and boosts their well-being.
  • Centuries of spiritual and philosophical work describe hope as a virtue that, like love, is a decision, not a feeling.

The myth of time

  • He faced repeated waves of criticism, and, at the time of his death, fewer Americans approved of him than of the Vietnam War.
  • In “Letter from a Birmingham Jail,” King lamented the optimism of moderate white Americans who said they supported his goals but took little action.
  • There is a “strangely irrational notion that there is something in the very flow of time that will inevitably cure all ills,” he wrote.


King was not alone in leveraging virtuous hope for justice. Brazilian educator Paulo Freire described hope as an “existential imperative” that promotes action. Nelson Mandela, who spent 27 years in prison, called hope a “powerful weapon.”

Forged in adversity

  • I study virtuous hope in a South African Zulu community, where there are few reasons for optimism.
  • This is the part of the country where HIV is most widespread, with the percentage near 50% in some communities.
  • These individuals demonstrated an unwavering focus on striving for a better future, often unglued from expectations of personal success.
  • Like King’s, it manifests in hardship and is refined in adversity.
  • Hope enables communities to march for justice and democracy even while tasting the danger of dictatorship, apartheid or oligarchy.


Kendra Thomas receives funding from the John Templeton Foundation

Positive+1, the Social Networking Platform Empowering the HIV Community Exhibits at South by Southwest Festival in Austin, TX

Retrieved on: 
Monday, March 11, 2024

The highly anticipated platform for connection, education, guidance and support - launched in seven countries in November 2023, enters its primary year as an exhibitor at South by Southwest Festival as part of the creative industries expo.

Key Points: 
  • Austin, Texas--(Newsfile Corp. - March 11, 2024) - Positive+1, the 'all-in-one' social networking platform designed for those living with, affected by, and working within HIV, enters its first year as an exhibitor at South by Southwest Festival (SXSW).
  • Recently launched in November 2023 in the United States, Canada, United Kingdom, South Africa, Australia & New Zealand, the platform marks a first of its kind globally - as there is no other platform currently available for the HIV community.
  • Positive+1 is attending SXSW for brand awareness and promotion to help those within the HIV community to connect.
  • To view an enhanced version of this graphic, please visit:
    Positive+1 is available for download via the Apple App Store and Google Play Store.

ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication

Retrieved on: 
Wednesday, March 6, 2024

“ACTG is thrilled to present this ground-breaking study at CROI,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California Los Angeles.

Key Points: 
  • “ACTG is thrilled to present this ground-breaking study at CROI,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California Los Angeles.
  • Participants received incentives and support to adhere to their daily oral medication to first achieve viral suppression and if successful, they were randomized to either receive long-acting injectable treatment every four weeks or continue taking daily oral medication.
  • The long-acting injectable treatment was more effective than the daily oral medication at maintaining virologic suppression and avoiding treatment-related discontinuation.
  • Twenty-eight participants receiving the long-acting injectable treatment experienced regimen failure (defined as virologic failure or treatment discontinuation), compared to 47 receiving daily oral medication.

ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination

Retrieved on: 
Wednesday, March 6, 2024

These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.

Key Points: 
  • These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.
  • People living with HIV, especially those with lower CD4 counts, often do not develop protective antibodies after receiving conventional hepatitis B vaccines.
  • The HepB-CpG (HEPLISAV-B®) vaccine includes a TLR-9 agonist adjuvant (CpG 1018® adjuvant) and is known to achieve high protection against hepatitis B among people living with HIV, but until now there have been limited data about its protection among people living with HIV who have not responded to conventional hepatitis B vaccines.
  • “Hepatitis B remains a significant issue for people living with HIV, as having both viruses increases the likelihood of liver complications,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California Los Angeles.